Familial Chylomicronemia Syndrome

Disease State Hub

Q&As

Expert Q&A

Expert Q&A

Managing sHTG: How to Identify Chylomicronemia Syndrome and Reduce Pancreatitis Risk

07/13/2026

Robert Hegele, MD

In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...

07/13/2026

Research Summaries

Research Summary

Research Summary

Study: Olezarsen Reduces Triglycerides in Familial Chylomicronemia Syndrome

01/20/2025

Miranda Manier, BA

A phase 3 clinical trial demonstrates the efficacy of olezarsen in reducing plasma triglycerides and acute pancreatitis episodes in patients with familial chylomicronemia syndrome.

01/20/2025

FDA Alert

FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome

01/13/2025

Miranda Manier, BA

Plozasiran, a first-in-class RNA interference therapeutic, reduced triglycerides by 80% and lowered the risk of acute pancreatitis by 83% in patients with familial chylomicronemia syndrome, earning FDA...

01/13/2025

Familial Chylomicronemia Syndrome

Familial Chylomicronemia Syndrome

Dyslipidemia Screening and Management in Primary Care Practice: A Look Beyond the Numbers

09/07/2016

One-third of US adults have elevated low-density lipoprotein cholesterol levels, a condition that is most often diagnosed and treated in primary care. Appropriate screening helps identify these patients...

09/07/2016

July 2026

Current Issue

July 2026